The past decade has seen exciting progress in the field of thyroid disease, especially in the evaluation of thyroid nodules, the genomic characterization of carcinomas and the treatment of carcinomas after surgery. An improved understanding of hyperthyroidism during pregnancy, as well as the causes of 'low T3 syndrome' and consumptive hypothyroidism have also been achieved.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The combination of nonthyroidal illness syndrome and renal dysfunction further increases mortality risk in patients with acute myocardial infarction: a prospective cohort study
BMC Cardiovascular Disorders Open Access 04 March 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cibas, E. S. & Ali, S. Z. The Bethesda system for reporting thyroid cytopathology. Thyroid 19, 1159–1165 (2009).
Alexander, E. K. et al. Multicentre clinical experience with the Afirma gene expression classifier. Clin. Endocrinol. Metab. 99, 19–25 (2014).
Xing, M. et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. Clin. Oncol. 33, 42–50 (2015).
Ho, A. L. et al. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. N. Engl. J. Med. 368, 623–632 (2013).
Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676–690 (2014).
Schlumberger, M. et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. Tumeurs de la Thyroïde Refractaires Network for the Essai Stimulation Ablation Equivalence Trial. N. Engl. J. Med. 366, 1663–1673 (2012).
Mallick, U. et al. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. N. Engl. J. Med. 366, 1674–1685 (2012).
Maynard, M. A. et al. Thyroid hormone inactivation in gastrointestinal stromal tumors. N. Engl. J. Med. 37, 1327–1334 (2014).
Andersen, S. L., Olsen, J., Wu, C. S. & Laurberg, P. Severity of birth defects after propylthiouracil exposure in early pregnancy. Thyroid 24, 1533–1540 (2014).
Wajner, S. M. et al. IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. J. Clin. Invest. 121, 1834–1845 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Larsen, P. The endocrinology of thyroid disease from 2005 to 2015. Nat Rev Endocrinol 11, 634–636 (2015). https://doi.org/10.1038/nrendo.2015.169
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2015.169
